Skip to Content

Notice

Grant Of Authority For Subzone Status, Merck & Co., Inc., (Vaccine Pharmaceuticals), Durham, North Carolina

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to its authority under the Foreign-Trade Zones Act of June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade Zones Board (the Board) adopts the following Order:

Whereas, the Foreign-Trade Zones Act provides for “ . . . the establishment . . . of foreign-trade zones in ports of entry of the United States, to expedite and encourage foreign commerce, and for other purposes,” and authorizes the Foreign-Trade Zones Board to grant to qualified corporations the privilege of establishing foreign-trade zones in or adjacent to U.S. Customs and Border Protection ports of entry;

Whereas, the Board's regulations (15 CFR Part 400) provide for the establishment of special-purpose subzones when existing zone facilities cannot serve the specific use involved, Start Printed Page 74486and when the activity results in a significant public benefit and is in the public interest;

Whereas, the Triangle J Council of Governments, grantee of FTZ 93, has made application to the Board for authority to establish special-purpose subzone status at the vaccine pharmaceutical manufacturing plant of Merck & Co., Inc., located in Durham, North Carolina (FTZ Docket 64-2005, filed 12/15/05);

Whereas, notice inviting public comment has been given in the Federal Register (70 FR 76444, 12/27/05); and, WHEREAS, the Board adopts the findings and recommendations of the examiner's report, and finds that the requirements of the FTZ Act and the Board's regulations are satisfied, and that approval of the application is in the public interest;

Now therefore, the Board hereby grants authority for subzone status for activity related to vaccine pharmaceutical manufacturing at the Merck & Co., Inc., facility located in Durham, North Carolina (Subzone 93H), as described in the application and Federal Register notice, and subject to the FTZ Act and the Board's regulations, including Section 400.28.

Signed at Washington, DC, this 1st day of December 2006.

Start Signature

David M. Spooner,

Assistant Secretary of Commerce for Import Administration, Alternate Chairman, Foreign-Trade Zones Board

Attest:

Andrew McGilvray,

Acting Executive Secretary.

End Signature End Preamble

[FR Doc. E6-20946 Filed 12-8-06; 8:45 am]

BILLING CODE 3510-DS-S